enVVeno Medical Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$20.9M | -$23.8M | -$25.2M | -$24.9M | -$16.9M |
| Cash from operations | -$15.6M | -$16.8M | -$18.9M | -$15.6M | -$11.8M |
| Capital expenditure | $5,000 | $37,000 | $33,000 | $115,000 | $368,000 |
| Free cash flow | -$15.6M | -$16.9M | -$18.9M | -$15.7M | -$12.2M |
| Total assets | $29.6M | $45.0M | $48.6M | $41.7M | $57.7M |
| Total liabilities | $2.4M | $2.8M | $2.4M | $2.9M | $3.3M |
Shares outstanding 667.7K · Free float 92.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.